Inventor

PEYMAN ANUSCHIRWAN

DE43 patents

⚠️ This page may combine multiple inventors who share the name “PEYMAN ANUSCHIRWAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

PEYMAN ANUSCHIRWAN

HOECHST AG

G cap-stabilized oligonucleotides

Stabilized oligonucleotides and their use

Phosphonomonoester nucleic acids, process for their preparation, and their use

Antisense oligonucleotides against HSV 1, and their preparation

Substituted purine derivatives, processes for their preparation, their use, and compositions comprising them

Phosphonomonoester nucleic acids process for their preparation and their use

Oligonucleotide analogs, their preparation and use

3&#39;-modified oligonucleotide derivatives

Vitronectin receptor antagonists, their preparation and their use

Vitronectin receptor antagonists, their preparation and their use

Vitronectin receptor antagonists, their preparation and their use

Vitronectin receptor anatagonists, their preparation and their use

3&#39;-derivatized oligonucleotide analogs with non-nucleotidic groupings, their preparation and use

Phosphinic acid derivatives, their preparation and their use

Prodrug derivatives of enzyme inhibitors having hydroxyl groups, a process for preparing them, and their use

Vitronectin receptor antagonists, their preparation and their use

Vitronectin receptor antagonists, their preparation and their use

2-formylbenzylphosphonic acid derivatives useful for the treatment of diseases caused by viruses

Process for the preparation of 1-hydroxy-2-pyridones

Use of benzylphosphonic acid derivatives for the treatment of diseases caused by viruses

Bis(aminomethyl)phosphinic acid derivatives and process for the preparation of bis(aminomethyl)phosphinic acid derivatives

Process for the preparation of 1-hydroxy-2-pyridones

Inhibitors of retroviral proteases

Inhibitors of retroviral proteases

Process for the preparation of derivatives of bis(amino-methyl) phosphinic acid

AVENTIS PHARMA GMBH

Oxybenzamide derivatives useful for inhibiting factor Xa or viia

G cap-stabilized oligonucleotides

Guanidine derivatives as inhibitors of cell adhesion

Sulfonamide derivatives as inhibitors of bone resorption and as inhibitors of cell adhesion

3 modified oligonucleotide derivatives

Substituted purine derivatives as inhibitors of cell adhesion

Acylguanidine derivatives as inhibitors of bone resorption and as vitronectin receptor antagonists

Process for the preparation of birthonectin receptor antagonists

Modified antisense nucleotides complementary to a section of the human Ha-ras gene

Antisense oligonucleotides against tenascin for treating vitiligo

(2S)-2-(adamantan-1-ylmethoxycarbonylamino)-3-(4-(2-(1,4,5,6-tetrhydropyrimidin-2-ylcarbamoyl)ethyl)benzoylamino)propionic acid isopropyl ester, its preparation and its use

SANOFI AVENTIS DEUTSCHLAND

G cap-stabilized oligonucleotides

Oxybenzamide derivatives useful for inhibiting factor Xa or Vlla

Guanidine and amidine derivatives as factor Xa inhibitors

HOECHST MARION ROUSSEL DE GMBH

Sulfonamide derivatives as inhibitors of bone resorption and as inhibitors of cell adhesion

HOECHST ATKIENGESELLSCHAFT

Vitronectin receptor antagonists, their preparation and use

GENENTECH INC

Guanidino derivatives as inhibitors of cell adhesion

AVENTIS PHARMA S A DEUTSCHLAND

Thienylalanine derivatives as inhibitors of cell adhesion

3'-modified oligonucleotide derivatives

3'-derivatized oligonucleotide analogs with non-nucleotidic groupings, their preparation and use